These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 39063024)

  • 1. Opioid-Based Haptens: Development of Immunotherapy.
    Hosztafi S; Galambos AR; Köteles I; Karádi DÁ; Fürst S; Al-Khrasani M
    Int J Mol Sci; 2024 Jul; 25(14):. PubMed ID: 39063024
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Liposomes containing monophosphoryl lipid A: a potent adjuvant system for inducing antibodies to heroin hapten analogs.
    Matyas GR; Mayorov AV; Rice KC; Jacobson AE; Cheng K; Iyer MR; Li F; Beck Z; Janda KD; Alving CR
    Vaccine; 2013 Jun; 31(26):2804-10. PubMed ID: 23624097
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preclinical Efficacy and Characterization of Candidate Vaccines for Treatment of Opioid Use Disorders Using Clinically Viable Carrier Proteins.
    Baruffaldi F; Kelcher AH; Laudenbach M; Gradinati V; Limkar A; Roslawski M; Birnbaum A; Lees A; Hassler C; Runyon S; Pravetoni M
    Mol Pharm; 2018 Nov; 15(11):4947-4962. PubMed ID: 30240216
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Self-Adjuvanting TLR7/8 Agonist and Fentanyl Hapten Co-Conjugate Achieves Enhanced Protection against Fentanyl Challenge.
    Powers N; Massena C; Crouse B; Smith M; Hicks L; Evans JT; Miller S; Pravetoni M; Burkhart D
    Bioconjug Chem; 2023 Oct; 34(10):1811-1821. PubMed ID: 37758302
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy, but not antibody titer or affinity, of a heroin hapten conjugate vaccine correlates with increasing hapten densities on tetanus toxoid, but not on CRM197 carriers.
    Jalah R; Torres OB; Mayorov AV; Li F; Antoline JF; Jacobson AE; Rice KC; Deschamps JR; Beck Z; Alving CR; Matyas GR
    Bioconjug Chem; 2015 Jun; 26(6):1041-53. PubMed ID: 25970207
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Conjugate Vaccine Immunotherapy for Substance Use Disorder.
    Bremer PT; Janda KD
    Pharmacol Rev; 2017 Jul; 69(3):298-315. PubMed ID: 28634286
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improvements on a chemically contiguous hapten for a vaccine to address fentanyl-contaminated heroin.
    Park H; Lee JC; Eubanks LM; Ellis B; Zhou B; Janda KD
    Bioorg Med Chem; 2021 Jul; 41():116225. PubMed ID: 34034147
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hapten-specific naïve B cells are biomarkers of vaccine efficacy against drugs of abuse.
    Taylor JJ; Laudenbach M; Tucker AM; Jenkins MK; Pravetoni M
    J Immunol Methods; 2014 Mar; 405():74-86. PubMed ID: 24462800
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hapten optimization for cocaine vaccine with improved cocaine recognition.
    Ramakrishnan M; Kinsey BM; Singh RA; Kosten TR; Orson FM
    Chem Biol Drug Des; 2014 Sep; 84(3):354-63. PubMed ID: 24803171
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prescreening of Nicotine Hapten Linkers in Vitro To Select Hapten-Conjugate Vaccine Candidates for Pharmacokinetic Evaluation in Vivo.
    Arutla V; Leal J; Liu X; Sokalingam S; Raleigh M; Adaralegbe A; Liu L; Pentel PR; Hecht SM; Chang Y
    ACS Comb Sci; 2017 May; 19(5):286-298. PubMed ID: 28383252
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heat shock proteins: A dual carrier-adjuvant for an anti-drug vaccine against heroin.
    Hwang CS; Ellis B; Zhou B; Janda KD
    Bioorg Med Chem; 2019 Jan; 27(1):125-132. PubMed ID: 30497790
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The frequency of early-activated hapten-specific B cell subsets predicts the efficacy of vaccines for nicotine dependence.
    Laudenbach M; Tucker AM; Runyon SP; Carroll FI; Pravetoni M
    Vaccine; 2015 Nov; 33(46):6332-9. PubMed ID: 26409811
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design, Synthesis, and In Vivo Evaluation of C1-Linked 4,5-Epoxymorphinan Haptens for Heroin Vaccines.
    Sulima A; Li F; Morgan JB; Truong P; Antoline JFG; Oertel T; Barrientos RC; Torres OB; Beck Z; Imler GH; Deschamps JR; Matyas GR; Jacobson AE; Rice KC
    Molecules; 2022 Feb; 27(5):. PubMed ID: 35268659
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization and optimization of heroin hapten-BSA conjugates: method development for the synthesis of reproducible hapten-based vaccines.
    Torres OB; Jalah R; Rice KC; Li F; Antoline JF; Iyer MR; Jacobson AE; Boutaghou MN; Alving CR; Matyas GR
    Anal Bioanal Chem; 2014 Sep; 406(24):5927-37. PubMed ID: 25084736
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alum adjuvant is more effective than MF59 at prompting early germinal center formation in response to peptide-protein conjugates and enhancing efficacy of a vaccine against opioid use disorders.
    Robinson C; Baehr C; Schmiel SE; Accetturo C; Mueller DL; Pravetoni M
    Hum Vaccin Immunother; 2019; 15(4):909-917. PubMed ID: 30625019
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An Advance in Prescription Opioid Vaccines: Overdose Mortality Reduction and Extraordinary Alteration of Drug Half-Life.
    Kimishima A; Wenthur CJ; Zhou B; Janda KD
    ACS Chem Biol; 2017 Jan; 12(1):36-40. PubMed ID: 28103678
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adjuvants for vaccines to drugs of abuse and addiction.
    Alving CR; Matyas GR; Torres O; Jalah R; Beck Z
    Vaccine; 2014 Sep; 32(42):5382-9. PubMed ID: 25111169
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Engineering of a hybrid nanoparticle-based nicotine nanovaccine as a next-generation immunotherapeutic strategy against nicotine addiction: A focus on hapten density.
    Zhao Z; Powers K; Hu Y; Raleigh M; Pentel P; Zhang C
    Biomaterials; 2017 Apr; 123():107-117. PubMed ID: 28167389
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selection of a novel anti-nicotine vaccine: influence of antigen design on antibody function in mice.
    Pryde DC; Jones LH; Gervais DP; Stead DR; Blakemore DC; Selby MD; Brown AD; Coe JW; Badland M; Beal DM; Glen R; Wharton Y; Miller GJ; White P; Zhang N; Benoit M; Robertson K; Merson JR; Davis HL; McCluskie MJ
    PLoS One; 2013; 8(10):e76557. PubMed ID: 24098532
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Photochemical linking of primary aromatic amines to carrier proteins to elicit antibody response against the amine haptens.
    Pandey RN; Davis LE; Anderson B; Hollenberg PF
    J Immunol Methods; 1986 Nov; 94(1-2):237-46. PubMed ID: 3782813
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.